tag:blogger.com,1999:blog-42210549258408204472024-03-04T20:27:12.404-08:0014th Global Pharmacovigilance & Clinical Trials Summit<b>Theme:</b> Promulgating the prevention of adverse drug reaction<br>
<b>Date:</b> February 12-13, 2020 <br>
<b>Conference Venue:</b> Sydney, Australia Pharmaceutica Conferencehttp://www.blogger.com/profile/00120422206847995770noreply@blogger.comBlogger17125tag:blogger.com,1999:blog-4221054925840820447.post-46975780451832420632019-03-21T23:00:00.000-07:002019-03-21T23:20:19.261-07:00Final Announcement for Global Pharmacovigilance 2019<div dir="ltr" style="text-align: left;" trbidi="on">
<div align="center" class="MsoNormal" style="text-align: center;">
<span style="color: cyan;"><span style="font-family: "cambria" , serif;">13th Global Pharmacovigilance and clinical trials summit<br />March 28-29, 2019<br />Osaka, Japan</span><span style="font-family: "cambria" , serif;"><o:p></o:p></span></span></div>
<div class="MsoNormal">
<div style="text-align: left;">
<span style="color: cyan;"><span style="color: #222222; font-family: "cambria" , serif; mso-ascii-theme-font: major-latin; mso-bidi-font-family: Arial; mso-hansi-theme-font: major-latin;"><br />
</span><span style="color: #0f243e; font-family: "cambria" , serif; mso-ascii-theme-font: major-latin; mso-bidi-font-family: Arial; mso-hansi-theme-font: major-latin; mso-themecolor: text2; mso-themeshade: 128;">Dear <o:p></o:p></span></span></div>
</div>
<div class="MsoNormal">
<span style="color: cyan; font-family: "cambria" , serif; mso-ascii-theme-font: major-latin; mso-bidi-font-family: Calibri; mso-hansi-theme-font: major-latin; mso-themecolor: text2; mso-themeshade: 128;">It is an honor for us to invite you as a speaker/Delegate at Global Pharmacovigilance 2019 which is scheduled to be held in the month of March 28-29, in the magnificent city of Osaka, Japan.</span><span style="color: cyan; font-family: "cambria" , serif;"> The conference will feature interactive get together of researchers, scientists, students and entrepreneurs illuminating the facts and recent researches in the sward of Pharmacovigilance.</span></div>
<div class="MsoNormal">
<span style="color: cyan;"><br /></span></div>
<div class="MsoNormal">
<div class="MsoNormal">
<span style="background-color: black; color: cyan; font-family: "cambria" , serif;">Our confirmed Speakers:<o:p></o:p></span></div>
<div class="MsoNormal">
<span style="background-color: black; color: cyan;"><span style="font-family: "cambria" , serif;">Dr. Jacob Joseph, Harward Medical School, USA</span><span style="font-family: "cambria" , serif;"><o:p></o:p></span></span></div>
<div class="MsoNormal">
<span style="background-color: black; color: cyan;"><span style="font-family: "cambria" , serif;">Dr.Ujwala Salvi, Nucleon Therapeutics, India</span><span style="font-family: "cambria" , serif;"><o:p></o:p></span></span></div>
<div class="MsoNormal">
<span style="background-color: black; color: cyan; font-family: "cambria" , serif;">Mr. Chi Chen, E&Y, China </span></div>
<div class="MsoNormal">
<span style="background-color: black; color: cyan;"><span style="font-family: "cambria" , serif;">Dr. Meenal Patwardhan, AbbVie, USA</span><span style="font-family: "cambria" , serif;"><o:p></o:p></span></span></div>
<div class="MsoNormal">
<span style="background-color: black; color: cyan;"><span style="font-family: "cambria" , serif;">Mr. Rajiv Joshi, E&Y, India</span><span style="font-family: "cambria" , serif;"><o:p></o:p></span></span></div>
<div class="MsoNormal">
<span style="background-color: black; color: cyan;"><span style="font-family: "cambria" , serif;">Dr. Essam, Celyad llc, Belgium</span><span style="font-family: "cambria" , serif;"><o:p></o:p></span></span></div>
<div class="MsoNormal">
<span style="background-color: black; color: cyan;"><span style="font-family: "cambria" , serif;">Dr. Carole, Sun Pharma, Japan</span><span style="font-family: "cambria" , serif;"><o:p></o:p></span></span></div>
<div class="MsoNormal">
<span style="background-color: black; color: cyan;"><span style="font-family: "cambria" , serif;">Mr. Robert, Accenture, Spain</span><span style="font-family: "cambria" , serif;"><o:p></o:p></span></span></div>
<div class="MsoNormal">
<span style="background-color: black; color: cyan;"><span style="font-family: "cambria" , serif;">Mr. Ravish Kumar, Salzman Group, Australia</span><span style="font-family: "cambria" , serif;"><o:p></o:p></span></span></div>
<div class="MsoNormal">
<span style="background-color: black; color: cyan;"><span style="font-family: "cambria" , serif;">Dr. Abdeen, Ministry of health, UK.</span><span style="font-family: "cambria" , serif;"><o:p></o:p></span></span></div>
<div class="MsoNormal">
<span style="background-color: black; color: cyan;"><span style="font-family: "cambria" , serif;">Dr. Ripal Gharia, Cliantha research, India</span><span style="font-family: "cambria" , serif;"><o:p></o:p></span></span></div>
<div class="MsoNormal">
<span style="background-color: black; color: cyan;"><span style="font-family: "cambria" , serif;">Mr. Mohammed Gayoor khan, NFPS, Malaysia</span><span style="font-family: "cambria" , serif;"><o:p></o:p></span></span></div>
<div class="MsoNormal">
<span style="background-color: black; color: cyan;"><span style="font-family: "cambria" , serif;">Dr. lorelei, Vice President, Pepgen Corporation, USA</span><span style="font-family: "cambria" , serif;"><o:p></o:p></span></span></div>
<div class="MsoNormal">
<span style="background-color: black; color: cyan;"><span style="font-family: "cambria" , serif;">Dr. Muhammed Waser Anwar, Evolet Healthcare Pvt Limited,India.</span><span style="font-family: "cambria" , serif;"><o:p></o:p></span></span></div>
<div class="MsoNormal">
<span style="background-color: black; color: cyan; font-family: "cambria" , serif;">Dr. Jean Wright, Abbvie, USA.</span><span style="color: #0f243e; font-family: "cambria" , serif; mso-ascii-theme-font: major-latin; mso-bidi-font-family: Calibri; mso-hansi-theme-font: major-latin; mso-themecolor: text2; mso-themeshade: 128;"><o:p></o:p></span></div>
<br />
<div class="MsoNormal" style="margin-left: .25in;">
<br /></div>
</div>
<div class="MsoNormal">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgqd8ghjTWiJToPC9jB8YnJ6Qad_bn2lyK-dgK_2mmSXdsmJzSyVt3L6ikceKSFc5FtZPSU5RjBSbhHEopNuDfnoBeYp9sts9kb8yQVGFJB9SRh8a0YY0VFyf2IYWr887h4iTnuN-Zf6_g/s1600/BeFunky-photo.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="183" data-original-width="275" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgqd8ghjTWiJToPC9jB8YnJ6Qad_bn2lyK-dgK_2mmSXdsmJzSyVt3L6ikceKSFc5FtZPSU5RjBSbhHEopNuDfnoBeYp9sts9kb8yQVGFJB9SRh8a0YY0VFyf2IYWr887h4iTnuN-Zf6_g/s1600/BeFunky-photo.jpg" /></a></div>
<span style="font-family: "cambria" , serif;"><span style="color: cyan;"><br /></span></span></div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal" style="margin-left: .25in;">
<span style="color: cyan;"><br /></span></div>
<div class="MsoNormal">
<span style="color: cyan; font-family: "cambria" , serif; mso-ascii-theme-font: major-latin; mso-bidi-font-family: Calibri; mso-hansi-theme-font: major-latin; mso-themecolor: text2; mso-themeshade: 128;">The honor of your noble presence will adorn the conference.<o:p></o:p></span></div>
<div class="MsoNormal">
<span style="color: cyan; font-family: "cambria" , serif; mso-ascii-theme-font: major-latin; mso-bidi-font-family: Calibri; mso-hansi-theme-font: major-latin; mso-themecolor: text2; mso-themeshade: 128;">We look forward to your presence. Kindly do reply to us about your interest.<o:p></o:p></span></div>
<div class="MsoNormal">
<span style="color: cyan;"><span style="font-family: "cambria" , serif;"><br /><span style="color: cyan;">Have a Good Day.<br />
</span></span><span style="font-family: "cambria" , serif;">Regards,<br />Zoey Williams | Program Manager</span></span><span style="color: #222222; font-family: "cambria" , serif; mso-ascii-theme-font: major-latin; mso-bidi-font-family: Calibri; mso-hansi-theme-font: major-latin;"><o:p></o:p></span></div>
</div>
Unknownnoreply@blogger.com15tag:blogger.com,1999:blog-4221054925840820447.post-77292594731883073232019-01-17T03:15:00.000-08:002019-01-17T03:15:05.656-08:00<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="MsoNormal" style="background: white; line-height: 12.65pt;">
<b><span lang="EN-IN" style="color: #000025; font-family: "Cambria",serif; mso-ansi-language: EN-IN; mso-bidi-font-family: Calibri;"><br /></span></b></div>
<h2 style="background: white; line-height: 12.65pt; text-align: left;">
<b><span lang="EN-IN" style="color: #000025; font-family: "Cambria",serif; mso-ansi-language: EN-IN; mso-bidi-font-family: Calibri;"> Plan your trip to Osaka, Japan</span></b></h2>
<div class="MsoNormal" style="background: white; line-height: 12.65pt;">
<b><span lang="EN-IN" style="color: #000025; font-family: "Cambria",serif; mso-ansi-language: EN-IN; mso-bidi-font-family: Calibri;"><br /></span></b></div>
<div class="MsoNormal" style="background: white; line-height: 12.65pt;">
<b><span lang="EN-IN" style="color: #000025; font-family: "Cambria",serif; mso-ansi-language: EN-IN; mso-bidi-font-family: Calibri;"><br /></span></b></div>
<div class="MsoNormal" style="background: white; line-height: 12.65pt;">
<b><span lang="EN-IN" style="color: #000025; font-family: "Cambria",serif; mso-ansi-language: EN-IN; mso-bidi-font-family: Calibri;">Theme: Promulgating the prevention of adverse drug reaction</span></b><span style="color: #222222; mso-ascii-font-family: Calibri; mso-bidi-font-family: Calibri; mso-hansi-font-family: Calibri;"><o:p></o:p></span></div>
<div class="MsoNormal" style="background: white; line-height: 12.65pt;">
<span lang="EN-IN" style="color: #000025; font-family: "Cambria",serif; mso-ansi-language: EN-IN; mso-bidi-font-family: Calibri;"><br /></span></div>
<div class="MsoNormal" style="background: white; line-height: 12.65pt;">
<span lang="EN-IN" style="color: #000025; font-family: "Cambria",serif; mso-ansi-language: EN-IN; mso-bidi-font-family: Calibri;">The conference offers richer experiences for Exhibitors, Sponsors, Plenary Sessions, keynote talks, Poster presentations, B2B meetings, and networking panels.<br />For Conference details, please visit</span><span lang="EN-IN" style="color: #222222; mso-ansi-language: EN-IN;">: <span style="text-decoration-line: underline;"></span><span class="m-3754166691417174083gmail-msohyperlink"><span lang="EN-IN" style="color: blue; mso-ansi-language: EN-IN;"><a data-mt-detrack-inspected="true" data-saferedirecturl="https://www.google.com/url?q=https://bit.ly/2HwRNwR&source=gmail&ust=1547803479970000&usg=AFQjCNFWPcaBA_S3x3ZH-8y_im1Lxxfo8Q" href="https://bit.ly/2HwRNwR" target="_blank"><span style="color: #1155cc;">https://bit.ly/2HwRNwR</span></a></span></span></span><span style="color: #222222; mso-ascii-font-family: Calibri; mso-bidi-font-family: Calibri; mso-hansi-font-family: Calibri;"><o:p></o:p></span></div>
<div class="MsoNormal" style="background: white; line-height: 12.65pt;">
<strong><span lang="EN-IN" style="color: #000025; font-family: "Cambria",serif; mso-ansi-language: EN-IN; mso-bidi-font-family: Calibri;"><br /></span></strong></div>
<div class="MsoNormal" style="background: white; line-height: 12.65pt;">
<strong><span lang="EN-IN" style="color: #000025; font-family: "Cambria",serif; mso-ansi-language: EN-IN; mso-bidi-font-family: Calibri;">Benefits</span></strong><span style="color: #222222; mso-ascii-font-family: Calibri; mso-bidi-font-family: Calibri; mso-hansi-font-family: Calibri;"><o:p></o:p></span></div>
<div class="m-3754166691417174083gmail-msolistparagraph" style="background: white; line-height: 12.65pt; margin: 0in 0in 0.0001pt 0.5in;">
<span lang="EN-IN" style="color: #000025; font-family: Symbol; mso-ansi-language: EN-IN; mso-bidi-font-family: Calibri;">·<span style="font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal;"></span><span lang="EN-IN" style="font-size: 7pt;"> </span></span><span lang="EN-IN" style="color: #000025; font-family: "Cambria",serif; mso-ansi-language: EN-IN; mso-bidi-font-family: Calibri;">Best platform to develop new partnership & collaborations.</span><span style="color: #222222; font-family: "Calibri",sans-serif; font-size: 11.0pt;"><o:p></o:p></span></div>
<div class="m-3754166691417174083gmail-msolistparagraph" style="background: white; line-height: 12.65pt; margin: 0in 0in 0.0001pt 0.5in;">
<span lang="EN-IN" style="color: #000025; font-family: Symbol; mso-ansi-language: EN-IN; mso-bidi-font-family: Calibri;">·<span style="font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal;"></span><span lang="EN-IN" style="font-size: 7pt;"> </span></span><span lang="EN-IN" style="color: #000025; font-family: "Cambria",serif; mso-ansi-language: EN-IN; mso-bidi-font-family: Calibri;">Network development with both Academia and Business.</span><span style="color: #222222; font-family: "Calibri",sans-serif; font-size: 11.0pt;"><o:p></o:p></span></div>
<div class="m-3754166691417174083gmail-msolistparagraph" style="background: white; line-height: 12.65pt; margin: 0in 0in 0.0001pt 0.5in;">
<span lang="EN-IN" style="color: #000025; font-family: Symbol; mso-ansi-language: EN-IN; mso-bidi-font-family: Calibri;">·<span style="font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal;"></span><span lang="EN-IN" style="font-size: 7pt;"> </span></span><span lang="EN-IN" style="color: #000025; font-family: "Cambria",serif; mso-ansi-language: EN-IN; mso-bidi-font-family: Calibri;">Recognition to your products and services in the world market through our website.</span><span style="color: #222222; font-family: "Calibri",sans-serif; font-size: 11.0pt;"><o:p></o:p></span></div>
<div class="m-3754166691417174083gmail-msolistparagraph" style="background: white; line-height: 12.65pt; margin: 0in 0in 0.0001pt 0.5in;">
<span lang="EN-IN" style="color: #000025; font-family: Symbol; mso-ansi-language: EN-IN; mso-bidi-font-family: Calibri;">·<span style="font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal;"></span><span lang="EN-IN" style="font-size: 7pt;"> </span></span><span lang="EN-IN" style="color: #000025; font-family: "Cambria",serif; mso-ansi-language: EN-IN; mso-bidi-font-family: Calibri;">Shape and raise your corporate image through logo branding.</span><span style="color: #222222; font-family: "Calibri",sans-serif; font-size: 11.0pt;"><o:p></o:p></span></div>
<div class="m-3754166691417174083gmail-msolistparagraph" style="background: white; line-height: 12.65pt; margin: 0in 0in 0.0001pt 0.5in;">
<span lang="EN-IN" style="color: #000025; font-family: Symbol; mso-ansi-language: EN-IN; mso-bidi-font-family: Calibri;">·<span style="font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal;"></span><span lang="EN-IN" style="font-size: 7pt;"> </span></span><span lang="EN-IN" style="color: #000025; font-family: "Cambria",serif; mso-ansi-language: EN-IN; mso-bidi-font-family: Calibri;">Special privileges on group registrations.</span><span style="color: #222222; font-family: "Calibri",sans-serif; font-size: 11.0pt;"><o:p></o:p></span></div>
<div class="m-3754166691417174083gmail-msolistparagraph" style="background: white; line-height: 12.65pt; margin: 0in 0in 0.0001pt 0.5in;">
<span lang="EN-IN" style="color: #000025; font-family: Symbol; mso-ansi-language: EN-IN; mso-bidi-font-family: Calibri;">·<span style="font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal;"></span><span lang="EN-IN" style="font-size: 7pt;"> </span></span><span lang="EN-IN" style="color: #000025; font-family: "Cambria",serif; mso-ansi-language: EN-IN; mso-bidi-font-family: Calibri;">Develop new client relationships and strengthen the existing ones (B2B Meeting).</span><span style="color: #222222; font-family: "Calibri",sans-serif; font-size: 11.0pt;"><o:p></o:p></span></div>
<div class="MsoNormal" style="background: white; line-height: 12.65pt;">
<br /></div>
<div class="MsoNormal" style="background: white; line-height: 12.65pt;">
<span lang="EN-IN" style="color: #000025; font-family: "Cambria",serif; mso-ansi-language: EN-IN; mso-bidi-font-family: Calibri;"><b>Participating Companies:</b></span><span style="color: #222222; mso-ascii-font-family: Calibri; mso-bidi-font-family: Calibri; mso-hansi-font-family: Calibri;"><o:p></o:p></span></div>
<div class="m-3754166691417174083gmail-msolistparagraph" style="background: white; line-height: 12.65pt; margin: 0in 0in 0.0001pt 0.5in;">
<span lang="EN-IN" style="color: #000025; font-family: Symbol; mso-ansi-language: EN-IN; mso-bidi-font-family: Calibri;">·<span style="font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal;"></span><span lang="EN-IN" style="font-size: 7pt;"> </span></span><span lang="EN-IN" style="color: #000025; font-family: "Cambria",serif; mso-ansi-language: EN-IN; mso-bidi-font-family: Calibri;">Abbvie,USA</span><span style="color: #222222; font-family: "Calibri",sans-serif; font-size: 11.0pt;"><o:p></o:p></span></div>
<div class="m-3754166691417174083gmail-msolistparagraph" style="background: white; line-height: 12.65pt; margin: 0in 0in 0.0001pt 0.5in;">
<span lang="EN-IN" style="color: #000025; font-family: Symbol; mso-ansi-language: EN-IN; mso-bidi-font-family: Calibri;">·<span style="font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal;"></span><span lang="EN-IN" style="font-size: 7pt;"> </span></span><span lang="EN-IN" style="color: #000025; font-family: "Cambria",serif; mso-ansi-language: EN-IN; mso-bidi-font-family: Calibri;">E&Y, China</span><span style="color: #222222; font-family: "Calibri",sans-serif; font-size: 11.0pt;"><o:p></o:p></span></div>
<div class="m-3754166691417174083gmail-msolistparagraph" style="background: white; line-height: 12.65pt; margin: 0in 0in 0.0001pt 0.5in;">
<span lang="EN-IN" style="color: #000025; font-family: Symbol; mso-ansi-language: EN-IN; mso-bidi-font-family: Calibri;">·<span style="font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal;"></span><span lang="EN-IN" style="font-size: 7pt;"> </span></span><span lang="EN-IN" style="color: #000025; font-family: "Cambria",serif; mso-ansi-language: EN-IN; mso-bidi-font-family: Calibri;">Salmanz Group, Australia</span><span style="color: #222222; font-family: "Calibri",sans-serif; font-size: 11.0pt;"><o:p></o:p></span></div>
<div class="m-3754166691417174083gmail-msolistparagraph" style="background: white; line-height: 12.65pt; margin: 0in 0in 0.0001pt 0.5in;">
<span lang="EN-IN" style="color: #000025; font-family: Symbol; mso-ansi-language: EN-IN; mso-bidi-font-family: Calibri;">·<span style="font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal;"></span><span lang="EN-IN" style="font-size: 7pt;"> </span></span><span lang="EN-IN" style="color: #000025; font-family: "Cambria",serif; mso-ansi-language: EN-IN; mso-bidi-font-family: Calibri;">Nucleon Therapetics, India</span><span style="color: #222222; font-family: "Calibri",sans-serif; font-size: 11.0pt;"><o:p></o:p></span></div>
<div class="m-3754166691417174083gmail-msolistparagraph" style="background: white; line-height: 12.65pt; margin: 0in 0in 0.0001pt 0.5in;">
<span lang="EN-IN" style="color: #000025; font-family: Symbol; mso-ansi-language: EN-IN; mso-bidi-font-family: Calibri;">·<span style="font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal;"></span><span lang="EN-IN" style="font-size: 7pt;"> </span></span><span lang="EN-IN" style="color: #000025; font-family: "Cambria",serif; mso-ansi-language: EN-IN; mso-bidi-font-family: Calibri;">Saudi Patient safety Center, Saudi</span><span style="color: #222222; font-family: "Calibri",sans-serif; font-size: 11.0pt;"><o:p></o:p></span></div>
<div class="m-3754166691417174083gmail-msolistparagraph" style="background: white; line-height: 12.65pt; margin: 0in 0in 0.0001pt 0.5in;">
<span lang="EN-IN" style="color: #000025; font-family: Symbol; mso-ansi-language: EN-IN; mso-bidi-font-family: Calibri;">·<span style="font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal;"></span><span lang="EN-IN" style="font-size: 7pt;"> </span></span><span lang="EN-IN" style="color: #000025; font-family: "Cambria",serif; mso-ansi-language: EN-IN; mso-bidi-font-family: Calibri;">AlphaBeta Pharma, UK</span><span style="color: #222222; font-family: "Calibri",sans-serif; font-size: 11.0pt;"><o:p></o:p></span></div>
<div class="m-3754166691417174083gmail-msolistparagraph" style="background: white; line-height: 12.65pt; margin: 0in 0in 0.0001pt 0.5in;">
<span lang="EN-IN" style="color: #000025; font-family: Symbol; mso-ansi-language: EN-IN; mso-bidi-font-family: Calibri;">·<span style="font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal;"></span><span lang="EN-IN" style="font-size: 7pt;"> </span></span><span lang="EN-IN" style="color: #000025; font-family: "Cambria",serif; mso-ansi-language: EN-IN; mso-bidi-font-family: Calibri;">King Abdullah Medical City (KAMC)</span><span style="color: #222222; font-family: "Calibri",sans-serif; font-size: 11.0pt;"><o:p></o:p></span></div>
<div class="m-3754166691417174083gmail-msolistparagraph" style="background: white; line-height: 12.65pt; margin: 0in 0in 12pt 0.5in;">
<span lang="EN-IN" style="color: #000025; font-family: Symbol; mso-ansi-language: EN-IN; mso-bidi-font-family: Calibri;">·<span style="font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal;"></span><span lang="EN-IN" style="font-size: 7pt;"> </span></span><span lang="EN-IN" style="color: #000025; font-family: "Cambria",serif; mso-ansi-language: EN-IN; mso-bidi-font-family: Calibri;">Takeda, USA</span><span style="color: #222222; font-family: "Calibri",sans-serif; font-size: 11.0pt;"><o:p></o:p></span></div>
<div class="MsoNormal" style="background: white; line-height: 12.65pt; margin-bottom: 12pt;">
<span lang="EN-IN" style="color: #000025; font-family: "Cambria",serif; mso-ansi-language: EN-IN; mso-bidi-font-family: Calibri;">Please let me know your confirmation at the earliest convenience.</span><span style="color: #222222; mso-ascii-font-family: Calibri; mso-bidi-font-family: Calibri; mso-hansi-font-family: Calibri;"><o:p></o:p></span></div>
<br />
<table border="0" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="background: white; width: 100%px;">
<tbody>
<tr>
<td style="padding: 0in 0in 0in 0in; width: 100.0%;" width="100%">
<div class="MsoNormal" style="line-height: 12.65pt;">
<b><span lang="EN-IN" style="color: #222222; font-family: "Times New Roman Georgia"; mso-ansi-language: EN-IN; mso-bidi-font-family: Calibri;"> Best Regards</span></b><span lang="EN-IN" style="color: #222222; font-family: "Times New Roman Georgia"; mso-ansi-language: EN-IN; mso-bidi-font-family: Calibri;"><br />
</span><span lang="EN-IN" style="color: #000025; font-family: "Cambria",serif; mso-ansi-language: EN-IN; mso-bidi-font-family: Calibri;"> Z</span><span lang="EN-IN" style="color: #222222; mso-ansi-language: EN-IN; mso-ascii-font-family: Calibri; mso-bidi-font-family: Calibri; mso-hansi-font-family: Calibri;">oey A Williams</span><span lang="EN-IN" style="color: #000025; font-family: "Cambria",serif; mso-ansi-language: EN-IN; mso-bidi-font-family: Calibri;">| Program Coordinator<br /> Global Pharmacovigilance 2019<br /> Ph: 4896666555 Ext:6028<br /> Email: <a data-mt-detrack-inspected="true" href="mailto:globalpharmocovigilance2019@gmail.com" target="_blank"><span style="color: #1155cc;">globalpharmocovigilance2019@<wbr></wbr>gmail.com</span></a></span><span style="color: #222222; mso-ascii-font-family: Calibri; mso-bidi-font-family: Calibri; mso-hansi-font-family: Calibri;"><o:p></o:p></span></div>
</td>
</tr>
</tbody></table>
</div>
Unknownnoreply@blogger.com1tag:blogger.com,1999:blog-4221054925840820447.post-31686881737193557002019-01-12T00:27:00.000-08:002019-01-12T00:33:59.309-08:00Mid Term Announcement of the conference- GPV 2019<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="MsoNormal" style="line-height: normal; margin-bottom: 0.0001pt; text-align: left;">
<strong><span style="font-family: "georgia" , serif; mso-bidi-font-family: Leelawadee;">Greetings of the day!!</span></strong></div>
<div class="MsoNormal" style="line-height: normal; margin-bottom: 0.0001pt; text-align: left;">
<strong><span style="font-family: "georgia" , serif; mso-bidi-font-family: Leelawadee;"><br /></span></strong></div>
<div class="MsoNormal" style="line-height: normal; margin-bottom: 0.0001pt; text-align: left;">
<div style="text-align: left;">
<span style="font-family: "georgia" , serif;">We heartily welcome all the participants throughout the globe to participate in the conference titled <a href="https://globalpharmacovigilance.pharmaceuticalconferences.com/">13th Global Pharmacovigilance and clinical trials summit</a>. This event would be a great opportunity to gather knowledge as well as experience in the field of pharmacovigilance and clinical trials.</span></div>
</div>
<div style="text-align: left;">
<span style="font-family: "georgia" , serif;"><br /></span>
<div style="text-align: left;">
<span style="font-family: "times new roman" , serif; font-size: 14pt;"><b>Session of the conference:</b></span></div>
<br />
<div style="text-align: left;">
<span style="font-family: "times new roman" , serif; font-size: 14pt; line-height: 115%;">Pre-Clinical and Clinical Trials</span></div>
<span style="font-family: "times new roman" , serif; font-size: 14pt; line-height: 115%;">Adverse Drug Reactions</span></div>
<div class="MsoNormal" style="text-align: left;">
<span style="font-family: "times new roman" , serif; font-size: 14pt; line-height: 115%;">Good Pharmacovigilance Practice</span><span style="font-family: "times new roman" , serif; font-size: 14pt; line-height: 115%;"><o:p></o:p></span></div>
<div class="MsoNormal" style="text-align: left;">
<span style="font-family: "times new roman" , serif; font-size: 14pt; line-height: 115%;">Drug Safety</span><span style="font-family: "times new roman" , serif; font-size: 14pt; line-height: 115%;"><o:p></o:p></span></div>
<div class="MsoNormal" style="text-align: left;">
<span style="font-family: "times new roman" , serif; font-size: 14pt; line-height: 115%;">Clinical Trial Protocols</span><span style="font-family: "times new roman" , serif; font-size: 14pt; line-height: 115%;"><o:p></o:p></span></div>
<div class="MsoNormal" style="text-align: left;">
<span style="font-family: "times new roman" , serif; font-size: 14pt; line-height: 115%;">Diversity in Industrial Clinical Trials and Clinical Research</span><span style="font-family: "times new roman" , serif; font-size: 14pt; line-height: 115%;"><o:p></o:p></span></div>
<div class="MsoNormal" style="text-align: left;">
<span style="font-family: "times new roman" , serif; font-size: 14pt; line-height: 115%;">Clinical Research and Statistics</span><span style="font-family: "times new roman" , serif; font-size: 14pt; line-height: 115%;"><o:p></o:p></span></div>
<div class="MsoNormal" style="text-align: left;">
<span style="font-family: "times new roman" , serif; font-size: 14pt; line-height: 115%;">Clinical Database Management</span><span style="font-family: "times new roman" , serif; font-size: 14pt; line-height: 115%;"><o:p></o:p></span></div>
<div class="MsoNormal" style="text-align: left;">
<span style="font-family: "times new roman" , serif; font-size: 14pt; line-height: 115%;">Medical and Clinical Case Reports</span><span style="font-family: "times new roman" , serif; font-size: 14pt; line-height: 115%;"><o:p></o:p></span></div>
<div class="MsoNormal" style="text-align: left;">
<span style="font-family: "times new roman" , serif; font-size: 14pt; line-height: 115%;">Hospital and Industrial Pharmacy</span><span style="font-family: "times new roman" , serif; font-size: 14pt; line-height: 115%;"><o:p></o:p></span></div>
<div class="MsoNormal" style="text-align: left;">
<span style="font-family: "times new roman" , serif; font-size: 14pt; line-height: 115%;">Clinical Data Management and Analytics</span><span style="font-family: "times new roman" , serif; font-size: 14pt; line-height: 115%;"><o:p></o:p></span></div>
<div class="MsoNormal" style="text-align: left;">
<span style="font-family: "times new roman" , serif; font-size: 14pt; line-height: 115%;">Clinical Trial Site Selection and Management</span><span style="font-family: "times new roman" , serif; font-size: 14pt; line-height: 115%;"><o:p></o:p></span></div>
<div class="MsoNormal" style="text-align: left;">
<span style="font-family: "times new roman" , serif; font-size: 14pt; line-height: 115%;">Medical and Clinical Case Reports</span><span style="font-family: "times new roman" , serif; font-size: 14pt; line-height: 115%;"><o:p></o:p></span></div>
<div class="MsoNormal" style="text-align: left;">
<span style="font-family: "times new roman" , serif; font-size: 14pt; line-height: 115%;">Biopharmaceutical Sciences</span><span style="font-family: "times new roman" , serif; font-size: 14pt; line-height: 115%;"><o:p></o:p></span></div>
<div class="gmail-msonospacing" style="margin: 0in 0in 0.0001pt; text-align: left;">
<span style="font-size: 14pt;">Our Confirmed Speakers:<o:p></o:p></span></div>
<div class="gmail-msonospacing" style="margin: 0in 0in 0.0001pt; text-align: left;">
<br /></div>
<div class="gmail-msonospacing" style="margin: 0in 0in 0.0001pt; text-align: left;">
<span style="font-size: 14pt;">Keynote:(Day 1)<o:p></o:p></span></div>
<div class="gmail-msonospacing" style="margin: 0in 0in 0.0001pt; text-align: left;">
<br /></div>
<div class="gmail-msonospacing" style="margin: 0in 0in 0.0001pt; text-align: left;">
<span style="font-size: 14pt;">Dr.Jacob Joseph, Harward Medical School, USA<o:p></o:p></span></div>
<div class="gmail-msonospacing" style="margin: 0in 0in 0.0001pt; text-align: left;">
<span style="font-size: 14pt;">Dr.Ujwala Salvi, Nucleon Therapeutics, India<o:p></o:p></span></div>
<div class="gmail-msonospacing" style="margin: 0in 0in 0.0001pt; text-align: left;">
<span style="font-size: 14pt;">Dr.Omer, Sanofi, Canada<o:p></o:p></span></div>
<div class="gmail-msonospacing" style="margin: 0in 0in 0.0001pt; text-align: left;">
<span style="font-size: 14pt;">Dr.Ashok, Clinfomatrix, USA<o:p></o:p></span></div>
<div class="gmail-msonospacing" style="margin: 0in 0in 0.0001pt; text-align: left;">
<br /></div>
<div class="gmail-msonospacing" style="margin: 0in 0in 0.0001pt; text-align: left;">
<span style="font-size: 14pt;">Other Speakers<o:p></o:p></span></div>
<div class="gmail-msonospacing" style="margin: 0in 0in 0.0001pt; text-align: left;">
<span style="font-size: 14pt;">Mr.Chi Chen, E&Y, China <o:p></o:p></span></div>
<div class="gmail-msonospacing" style="margin: 0in 0in 0.0001pt; text-align: left;">
<span style="font-size: 14pt;">Dr.Meenal Patwardhan, Abbvie, USA<o:p></o:p></span></div>
<div class="gmail-msonospacing" style="margin: 0in 0in 0.0001pt; text-align: left;">
<span style="font-size: 14pt;">Mr.Rajiv Joshi, E&Y, India<o:p></o:p></span></div>
<div class="gmail-msonospacing" style="margin: 0in 0in 0.0001pt; text-align: left;">
<br /></div>
<div class="gmail-msonospacing" style="margin: 0in 0in 0.0001pt; text-align: left;">
<span style="font-size: 14pt;">Keynote (Day 2)</span></div>
<div class="gmail-msonospacing" style="margin: 0in 0in 0.0001pt; text-align: left;">
<span style="font-size: 14pt;">Dr.Essam, Celyad, Belgium<o:p></o:p></span></div>
<div class="gmail-msonospacing" style="margin: 0in 0in 0.0001pt; text-align: left;">
<span style="font-size: 14pt;">Dr.Carole, Sun Pharma, Japan<o:p></o:p></span></div>
<div class="gmail-msonospacing" style="margin: 0in 0in 0.0001pt; text-align: left;">
<span style="font-size: 14pt;">Mr.Robert, Accenture, Spain<o:p></o:p></span></div>
<div class="gmail-msonospacing" style="margin: 0in 0in 0.0001pt; text-align: left;">
<span style="font-size: 14pt;">Session Speakers:<o:p></o:p></span></div>
<div class="gmail-msonospacing" style="margin: 0in 0in 0.0001pt; text-align: left;">
<br /></div>
<div class="gmail-msonospacing" style="margin: 0in 0in 0.0001pt; text-align: left;">
<span style="font-size: 14pt;">Mr.Ravish Kumar, Salzman Group, Australia<o:p></o:p></span></div>
<div class="gmail-msonospacing" style="margin: 0in 0in 0.0001pt; text-align: left;">
<span style="font-size: 14pt;">Dr.Abdeen, Ministry of health, UK.<o:p></o:p></span></div>
<div class="gmail-msonospacing" style="margin: 0in 0in 0.0001pt; text-align: left;">
<span style="font-size: 14pt;">Dr.Ripal Gharia, Cliantha research, India<o:p></o:p></span></div>
<div class="gmail-msonospacing" style="margin: 0in 0in 0.0001pt; text-align: left;">
<span style="font-size: 14pt;">Mr.Mohammed Gayoor khan,NFPS,Malaysia<o:p></o:p></span></div>
<div class="gmail-msonospacing" style="margin: 0in 0in 0.0001pt; text-align: left;">
<br /></div>
<div class="MsoNormal" style="text-align: left;">
<span lang="EN-IN" style="font-family: "times new roman" , serif; font-size: 14pt;">Participating Companies:</span><span style="font-family: "times new roman" , serif; font-size: 14pt;"><o:p></o:p></span></div>
<div class="gmail-m-315942351308248041gmail-msolistparagraph" style="margin: 0in 0in 0.0001pt 0.5in; text-align: left;">
<span lang="EN-IN" style="font-size: 14pt;">· Abbvie,USA</span><span style="font-size: 14pt;"><o:p></o:p></span></div>
<div class="gmail-m-315942351308248041gmail-msolistparagraph" style="margin: 0in 0in 0.0001pt 0.5in; text-align: left;">
<span lang="EN-IN" style="font-size: 14pt;">· E&Y, China</span><span style="font-size: 14pt;"><o:p></o:p></span></div>
<div class="gmail-m-315942351308248041gmail-msolistparagraph" style="margin: 0in 0in 0.0001pt 0.5in; text-align: left;">
<span lang="EN-IN" style="font-size: 14pt;">· Salmanz Group, Australia</span><span style="font-size: 14pt;"><o:p></o:p></span></div>
<div class="gmail-m-315942351308248041gmail-msolistparagraph" style="margin: 0in 0in 0.0001pt 0.5in; text-align: left;">
<span lang="EN-IN" style="font-size: 14pt;">· Nucleon Therapetics, India</span><span style="font-size: 14pt;"><o:p></o:p></span></div>
<div class="gmail-m-315942351308248041gmail-msolistparagraph" style="margin: 0in 0in 0.0001pt 0.5in; text-align: left;">
<span lang="EN-IN" style="font-size: 14pt;">· Saudi Patient safety Center, Saudi</span><span style="font-size: 14pt;"><o:p></o:p></span></div>
<div class="gmail-m-315942351308248041gmail-msolistparagraph" style="margin: 0in 0in 0.0001pt 0.5in; text-align: left;">
<span lang="EN-IN" style="font-size: 14pt;">· AlphaBeta Pharma, UK</span><span style="font-size: 14pt;"><o:p></o:p></span></div>
<div class="gmail-m-315942351308248041gmail-msolistparagraph" style="margin: 0in 0in 0.0001pt 0.5in; text-align: left;">
<span lang="EN-IN" style="font-size: 14pt;">· King Abdullah Medical City (KAMC)</span><span style="font-size: 14pt;"><o:p></o:p></span></div>
<div class="MsoNormal" style="line-height: normal; margin-bottom: 0.0001pt; text-align: left;">
</div>
<div class="gmail-m-315942351308248041gmail-msolistparagraph" style="margin: 0in 0in 12pt 0.5in; text-align: left;">
<span lang="EN-IN" style="font-size: 14pt;">· Takeda, USA</span><span style="font-size: 14pt;"><o:p></o:p></span></div>
<div class="gmail-m-315942351308248041gmail-msolistparagraph" style="margin-bottom: 12.0pt; margin-left: .5in; margin-right: 0in; margin-top: 0in; mso-line-height-alt: 12.65pt;">
<span lang="EN-IN" style="font-size: 14pt;"><br /></span></div>
<div class="gmail-m-315942351308248041gmail-msolistparagraph" style="margin-bottom: 12.0pt; margin-left: .5in; margin-right: 0in; margin-top: 0in; mso-line-height-alt: 12.65pt;">
<span lang="EN-IN" style="font-size: 14pt;"><br /></span></div>
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiKI8ZLX6SQfG9TxaSlY9hHz9BK0ElJ_JCm_vrNJL4_aPxGUi4xEyR4GQccfg5dBT0X1oBeAGQFI7yARapruE9qdNnD2U8t5370bS-1PjkeZ_UvTp1AUKmp5FMSYZ6ob4Z-9pEpeNedtZg/s1600/%2526.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="352" data-original-width="804" height="140" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiKI8ZLX6SQfG9TxaSlY9hHz9BK0ElJ_JCm_vrNJL4_aPxGUi4xEyR4GQccfg5dBT0X1oBeAGQFI7yARapruE9qdNnD2U8t5370bS-1PjkeZ_UvTp1AUKmp5FMSYZ6ob4Z-9pEpeNedtZg/s320/%2526.jpg" width="320" /></a></div>
<div class="gmail-m-315942351308248041gmail-msolistparagraph" style="margin-bottom: 12.0pt; margin-left: .5in; margin-right: 0in; margin-top: 0in; mso-line-height-alt: 12.65pt;">
<span lang="EN-IN" style="color: #000025; font-size: 14.0pt;"><br /></span></div>
</div>
Unknownnoreply@blogger.com17tag:blogger.com,1999:blog-4221054925840820447.post-38605436950717111522018-10-20T01:47:00.002-07:002018-10-20T01:47:20.109-07:00Conference Announcement-Global Pharmacovigilance 2019<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="MsoNormal">
Greetings of the day,<o:p></o:p></div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
This year is shaping up to be another exciting one for the Pharmacovigilance conference team. With nearly 30 Speakers already booked for the year, our thought leaders are looking forward to learning, networking, and presenting their work at a host of the event.<o:p></o:p></div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
Here is a sampling of our first quarter of the conference. We hope to see you in person very soon!!!!<o:p></o:p></div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
For more details visit: <strong><span style="font-family: "Georgia",serif; font-size: 11.0pt; font-weight: normal; line-height: 115%; mso-ansi-language: EN-US; mso-bidi-font-family: Leelawadee; mso-bidi-font-weight: bold; mso-bidi-language: AR-SA; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-US; mso-fareast-theme-font: minor-fareast;">https://bit.ly/2HwRNwR</span></strong></div>
<div class="MsoNormal">
<b><br /></b></div>
<div class="MsoNormal">
<b>Collaboration:</b><o:p></o:p></div>
<div class="MsoNormal">
NFPS-National Forum of Pharmacy students<o:p></o:p></div>
<div class="MsoNormal">
<b><br /></b></div>
<div class="MsoNormal">
<b>Media Partners:</b><o:p></o:p></div>
<div class="MsoNormal">
BioBased Press<o:p></o:p></div>
<div class="MsoNormal">
Tabeeby<o:p></o:p></div>
<div class="MsoNormal">
Japan Attractions<o:p></o:p></div>
<div class="MsoNormal">
Conference Locate<o:p></o:p></div>
<div class="MsoNormal">
Placidway<o:p></o:p></div>
<div class="MsoNormal">
<b><br /></b></div>
<div class="MsoNormal">
<b>Keynote Speakers:</b><o:p></o:p></div>
<div class="MsoNormal">
Dr.Jacob Joseph, USA<o:p></o:p></div>
<br />
<div class="MsoNormal">
Dr.Ashok Srivastava, USA</div>
</div>
Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-4221054925840820447.post-1953282119687609662018-06-25T04:10:00.000-07:002018-06-25T04:13:21.139-07:00Conference Announcement-Global Pharmacovigilance 2019<div dir="ltr" style="text-align: left;" trbidi="on">
We are happy to announce Almac's Group as Exhibitor at the upcoming “12th Global Pharmacovigilance & Clinical Trials Summit” ( Global Pharmacovigilance 2018) on July 16-17, 2018 <br />
<br />
Hurry up!! Slots are Limited!! Join us as a Speaker/ Delegate.<br />
<br />
To register : <a href="https://globalpharmacovigilance.pharmaceuticalconferences.com/registration.php">https://globalpharmacovigilance.pharmaceuticalconferences.com/registration.php</a><br />
<br />
For Queries E: <a href="mailto:globalpharmacovigilance123@gmail.com">globalpharmacovigilance123@gmail.com</a><br />
<div>
</div>
</div>
Unknownnoreply@blogger.com1tag:blogger.com,1999:blog-4221054925840820447.post-62971406974992153332018-06-15T01:46:00.003-07:002018-06-15T01:46:44.315-07:00<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEig1EkhM8ELpN8pFemn8abtBguFtJ3vidP9CLA7PLsp7r6ZFDoEUk1fz5SRr_eLUmVhbD_fFx3tjXkCf4PkFiQ4iXMi2sncHKoSfNUQLIEiIu8eXJK9MrRF3CYfq2aCPAcMDZ-K17nS954/s1600/banners+%25281%2529.png" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="400" data-original-width="700" height="182" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEig1EkhM8ELpN8pFemn8abtBguFtJ3vidP9CLA7PLsp7r6ZFDoEUk1fz5SRr_eLUmVhbD_fFx3tjXkCf4PkFiQ4iXMi2sncHKoSfNUQLIEiIu8eXJK9MrRF3CYfq2aCPAcMDZ-K17nS954/s320/banners+%25281%2529.png" width="320" /></a></div>
<span id="goog_723778518"></span><a href="https://www.blogger.com/"></a><span id="goog_723778519"></span><br />Join us! 12th Global Pharmacovigilance & Clinical Trials Summit | Few days ahead!! As we are few days away from 12th Global Pharmacovigilance & Clinical Trials Summit happening on July 16-17, 2018 in Sydney, Australia. <br /><br />Venue: Mercure Sydney, 818-820 George St, Sydney NSW 2007, Australia<br /><br /><br />GlobalPharmacovigilance2018 would lay a platform for the interaction between experts around the world and aims in accelerating scientific discovery.<div>
<br /></div>
<div>
<a href="http://globalpharmacovigilance.pharmaceuticalconferences.com/registration.php">http://globalpharmacovigilance.pharmaceuticalconferences.com/registration.php</a><br /><br />Expertise in Drug Discovery, Chemistry, Pre-Clinical Development, Clinicalresearch and Drugdevelopment, #Pharmacology and Pharmaceutics, Pharmacovigilance, Risk Management and Drugsafety, Clinicaloutcomes, Adverseevent Reporting System, Pharmacovigilance and its scope, Regulatory Safety Updates, Difficulties in Pre and Post marketing Surveillance, Biosimilars and Biologistics. and many more can share your research and listen to the expertise in the same field. <br /><br /><br />Email: globalpharmacovigilance123@gmail.com<br /><br /> globalpharmacovigilance@conferenceseries.net</div>
</div>
Unknownnoreply@blogger.com4tag:blogger.com,1999:blog-4221054925840820447.post-81020730393785905052018-06-08T01:10:00.004-07:002018-06-08T01:13:33.448-07:00<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhbwPpbgasP_mPr5ahViniAFnOfOn_bbaH1jLrbwjX0YbAMtmha2-A9YQGXRS2mqOxKyzR5sJ3B7kEDwpJq73T_7sjIOyKS7Jwv0gAOaoM1fBu5lA8cB1JDd4OxwdmnUFKg_jzzH_1Vo9E/s1600/images+121.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="128" data-original-width="393" height="130" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhbwPpbgasP_mPr5ahViniAFnOfOn_bbaH1jLrbwjX0YbAMtmha2-A9YQGXRS2mqOxKyzR5sJ3B7kEDwpJq73T_7sjIOyKS7Jwv0gAOaoM1fBu5lA8cB1JDd4OxwdmnUFKg_jzzH_1Vo9E/s400/images+121.jpg" width="400" /></a></div>
<br />
<br />
#GroupDiscount! <br />
<br />
<a href="https://globalpharmacovigilance.pharmaceuticalconferences.com/registration.php">https://globalpharmacovigilance.pharmaceuticalconferences.com/registration.php</a><br />
<br />
Email globalpharmacovigilance123@gmail.com for details! <br />
<br />
Participants interested to #register in group of 3 and more for #Globalpharmacovigilance2018 can contact us to avail #discounted prices. <br />
<br />
Researchers in #pharmacovigilance, #clinical trials, #biosimilars, #regulatoryaffairs, #drug safety, #epidemiology, #Pharmacology, #toxicology #clinicalresearch can actively take part in 12th Global Pharmacovigilance & Clinical Trials Summit | July 16-17, 2018 Sydney, Australia</div>
Unknownnoreply@blogger.com2tag:blogger.com,1999:blog-4221054925840820447.post-65834870618147212562018-06-07T03:51:00.004-07:002018-06-07T03:52:28.467-07:00<div dir="ltr" style="text-align: left;" trbidi="on">
<div>
Come Let’s Bring a Transformation in the Scientific Society :</div>
<div>
---------------------------------------------------------------------------<br />
<br />
The Young Researchers Forum offers young researchers the possibility to meet and discuss research topics and methodologies, share and develop ideas, learn from each other and gain knowledge from senior researchers.</div>
<div>
Meet leading experts in the field of Pharma, Pharmacy, pharmaceutical industry. Students can present their research<br />
<div>
<br /></div>
<div>
<a href="https://t.co/D2y5ch3irL">https://globalpharmacovigilance.pharmaceuticalconferences.com/young-researchers-forum.php</a></div>
<br />
Young Researcher Sessions are organized at the Global Pharmacovigilance 2018, to provide a unique platform for Young Researchers/Investigators for presenting latest research projects with an in-depth analysis. Conference Series LLC Ltd cordially invites Young Researchers from Universities/Institutes/Industries to present a short oral presentation during the forum. These oral presentations should be of 10-20 minutes duration in related scientific track followed by 5 minutes question hour. Therefore, presenters are encouraged to give comprehensive and dynamic talks.</div>
<div>
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg3AvrkdEWM53ldSEg9BgxdvllHnhN4gQXxAIPQzWio_88aAngmCMOkToLkLaWcJBhfthTO3mde8WLyq7u9HVeoVTEofzfVKUziaeZutqIJdQjSLTyzOZEe9chLPbfchald3StDcke54zk/s1600/Pathology2018-30000.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="280" data-original-width="855" height="130" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg3AvrkdEWM53ldSEg9BgxdvllHnhN4gQXxAIPQzWio_88aAngmCMOkToLkLaWcJBhfthTO3mde8WLyq7u9HVeoVTEofzfVKUziaeZutqIJdQjSLTyzOZEe9chLPbfchald3StDcke54zk/s400/Pathology2018-30000.jpg" width="400" /></a></div>
</div>
<div>
<br /></div>
<div>
For more details mail us at globalpharmacovigilance123@gmail.com</div>
</div>
Unknownnoreply@blogger.com3tag:blogger.com,1999:blog-4221054925840820447.post-6816287054398587722018-06-05T01:27:00.000-07:002018-06-15T01:47:56.648-07:00<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi_PhsAhrwpyvStybTEB1cuqEEIjSmFJH8SMPjTjmACRj3YG6sGOub-eis8E0p5_1zbnkKD7xNv6A5Sltb8QN-_mnfOSqzbnosJqI-ngdrL8KiWZ1F8rJIYXDqjkTcUhku3V50PRpT9Q9o/s1600/dementia2017-26175.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="280" data-original-width="855" height="104" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi_PhsAhrwpyvStybTEB1cuqEEIjSmFJH8SMPjTjmACRj3YG6sGOub-eis8E0p5_1zbnkKD7xNv6A5Sltb8QN-_mnfOSqzbnosJqI-ngdrL8KiWZ1F8rJIYXDqjkTcUhku3V50PRpT9Q9o/s320/dementia2017-26175.jpg" width="320" /></a></div>
<br />
<br />
<div class="MsoNormal">
<span style="font-family: "times new roman" , "serif"; font-size: 12.0pt; line-height: 115%;">Join us in #Australia to meet the #eminent persons
in the field of #Pharma, #Biotech and #HealthCare interested in
#Pharmacovigilance, #Clinicaltrials and #Drugsafety. <o:p></o:p></span><br />
<span style="color: #e36c0a; font-family: "times new roman" , serif; font-size: 12pt;"><br /></span>
<span style="color: #e36c0a; font-family: "times new roman" , serif; font-size: 12pt;">12<sup>th</sup> Global Pharmacovigilance
& Clinical Trials Summit</span><br />
<span style="color: #e36c0a; font-family: "times new roman" , serif; font-size: 12pt;">July
16-17, 2018 </span><br />
<span style="color: #e36c0a; font-family: "times new roman" , serif; font-size: 12pt;">Sydney, Australia</span></div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<span style="font-family: "times new roman" , "serif"; font-size: 12.0pt; line-height: 115%;">Register Now!!<o:p></o:p></span><br />
<span style="font-family: "times new roman" , "serif"; font-size: 12.0pt; line-height: 115%;"><br /></span>
<span style="font-family: "times new roman" , "serif"; font-size: 12.0pt; line-height: 115%;"><a href="http://globalpharmacovigilance.pharmaceuticalconferences.com/registration.php">http://globalpharmacovigilance.pharmaceuticalconferences.com/registration.php</a></span></div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<span style="font-family: "times new roman" , "serif"; font-size: 12.0pt; line-height: 115%;">For Queries mail us at
globalpharmacovigilance123@gmail.com<o:p></o:p></span></div>
<br />
<br />
<br /></div>
Unknownnoreply@blogger.com2tag:blogger.com,1999:blog-4221054925840820447.post-16606705162778184952018-06-04T03:05:00.002-07:002018-06-04T03:06:27.223-07:00<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgjvf6Sr81e72CuUK6K1431PWfs8DtROVd6IftfAhEcStQlG0L6RJPAYLhcNemfZVbyTOvxKF9MvvcyzNQmDssJjHiTCD8ioh1n_zOBKjsMUcU-MdDpby69oHMWzOla2IOJ11f9FanUXaY/s1600/speak-banner.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="400" data-original-width="1440" height="88" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgjvf6Sr81e72CuUK6K1431PWfs8DtROVd6IftfAhEcStQlG0L6RJPAYLhcNemfZVbyTOvxKF9MvvcyzNQmDssJjHiTCD8ioh1n_zOBKjsMUcU-MdDpby69oHMWzOla2IOJ11f9FanUXaY/s320/speak-banner.jpg" width="320" /></a></div>
Few <a href="https://www.linkedin.com/search/results/content/?keywords=%23Speaker&origin=HASH_TAG_FROM_FEED">#Speaker</a> slots left!!<br />
<div>
<br /></div>
<div>
<div>
<a href="https://www.linkedin.com/search/results/content/?keywords=%23Pharmacovigilance&origin=HASH_TAG_FROM_FEED">Pharmacovigilance</a> & <a href="https://www.linkedin.com/search/results/content/?keywords=%23Clinical&origin=HASH_TAG_FROM_FEED">#Clinical</a> Trials <a href="https://www.linkedin.com/search/results/content/?keywords=%23Summit&origin=HASH_TAG_FROM_FEED">#Summit</a> </div>
<div>
July 16-17, 2018 <a href="https://www.linkedin.com/search/results/content/?keywords=%23Sydney&origin=HASH_TAG_FROM_FEED">#Sydney</a>, <a href="https://www.linkedin.com/search/results/content/?keywords=%23Australia&origin=HASH_TAG_FROM_FEED">#Australia</a> </div>
<div>
<br /></div>
<div>
Hurry to <a href="https://www.linkedin.com/search/results/content/?keywords=%23submit&origin=HASH_TAG_FROM_FEED">#submit</a> your <a href="https://www.linkedin.com/search/results/content/?keywords=%23abstract&origin=HASH_TAG_FROM_FEED">#abstract</a> and <a href="https://www.linkedin.com/search/results/content/?keywords=%23enroll&origin=HASH_TAG_FROM_FEED">#enroll</a> your <a href="https://www.linkedin.com/search/results/content/?keywords=%23participation&origin=HASH_TAG_FROM_FEED">#participation</a> in <a href="https://www.linkedin.com/search/results/content/?keywords=%23Global&origin=HASH_TAG_FROM_FEED">#Global</a> Pharmacovigilance 2018 <a href="https://www.linkedin.com/search/results/content/?keywords=%23Conference&origin=HASH_TAG_FROM_FEED">#Conference</a>. </div>
<div>
<br /></div>
<div>
Submit your abstract @ <a href="https://lnkd.in/fjt8WES">https://lnkd.in/fjt8WES</a> <a href="https://www.linkedin.com/search/results/content/?keywords=%23Pharmacovigilance&origin=HASH_TAG_FROM_FEED">#</a></div>
<div>
<br /></div>
<div class="separator" style="clear: both; text-align: center;">
</div>
<div>
<br /></div>
<div>
For queries, mail us at <a href="mailto:globalpharmacovigilance123@gmail.com">globalpharmacovigilance123@gmail.com</a></div>
</div>
</div>
Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-4221054925840820447.post-67011906131735718292018-05-24T20:36:00.002-07:002018-05-24T21:04:18.074-07:00<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEglUMzcj3GU-TYFax-H20VHjQW-75ZJuwYAXTsQShELZzZsN-t1k9Kxp93-dGlezZp3T-35X62fnPLLuR18eKnL_QbZtTwV6ONYrutY0oN8TOzARVsNlj8e52SXavDE3pysTT4fn1993bs/s1600/Blog_Campaign_EB+%25281%2529+%25281%2529.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="336" data-original-width="702" height="153" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEglUMzcj3GU-TYFax-H20VHjQW-75ZJuwYAXTsQShELZzZsN-t1k9Kxp93-dGlezZp3T-35X62fnPLLuR18eKnL_QbZtTwV6ONYrutY0oN8TOzARVsNlj8e52SXavDE3pysTT4fn1993bs/s320/Blog_Campaign_EB+%25281%2529+%25281%2529.jpg" width="320" /></a></div>
<br />
<br />
Meet Inspiring Speakers and Experts at 12th Global Pharmacovigilance & Clinical Trials Summit on July 16-17, 2018 Sydney, Australia <br />
<br />
To book your slot... and confirm your registration, visit our online link<br />
https://globalpharmacovigilance.pharmaceuticalconferences.com/registration.php <br />
<br />
For queries, mail us at globalpharmacovigilance123@gmail.com</div>
Unknownnoreply@blogger.com1tag:blogger.com,1999:blog-4221054925840820447.post-4653091232909326712018-05-22T04:10:00.001-07:002018-05-22T04:10:15.669-07:00<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj9Mqj-5wY1E0JgK3WjsH21wKwghsQYzftVkGp8ij9lT8IfgEqjjryvwlHxndQAxqjx33CaeBAiGTFZRO8pA737mEiqcS-Iy5O7pLKPtBq4EQwrxmO-A6R0lPgKKIpk8PEgTpdt7-6inys/s1600/Track+3+%2528+Twitter%2529.png" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="187" data-original-width="380" height="157" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj9Mqj-5wY1E0JgK3WjsH21wKwghsQYzftVkGp8ij9lT8IfgEqjjryvwlHxndQAxqjx33CaeBAiGTFZRO8pA737mEiqcS-Iy5O7pLKPtBq4EQwrxmO-A6R0lPgKKIpk8PEgTpdt7-6inys/s320/Track+3+%2528+Twitter%2529.png" width="320" /></a></div>
<br />
<br />
<a href="https://globalpharmacovigilance.pharmaceuticalconferences.com/events-list/adverse-drug-reaction">Adverse Drug Reaction</a> (ADR) is that the contrary reaction caused by taking a medicine. several Adverse Drug Reactions represent an awesome facet effects of the drug's therapeutic effects and ar thanks to administration of single dose or prolonged usage of drug. These reactions ar caused by one drug or combination of multiple medication. ADRs is native i.e, restricted to bound location or it is general i.e, unfold throughout whole circulation. Acoording to US FDA an adverse drug reaction is severe once it ends up in death of patient or causes permanent harm or important incapacity in patient’s body functions. Adverse Drug Reactions of medicine is studied by reportage the mechanism of adverse drug reactions and maintaining the <a href="https://globalpharmacovigilance.pharmaceuticalconferences.com/">drug safety</a> systems. This track is concerning expected and un-expected drug reactions and its reportage makers, Professionals, and shoppers will report Post promoting reports on adverse effects.<br /><br />For more updates regarding the conference, mail us at globalpharmacovigilance123@gmail.com </div>
Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-4221054925840820447.post-35124208532648603332018-05-21T02:22:00.001-07:002018-05-21T02:24:13.519-07:00<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj52vn_ikZdB5YeOwI9bq-a3yBDpxbt4I6k2LKFW40eZKARKKfr5exhIzyBgC8WYT8yq5CSaOumYvrjwzjVEv2ZtgLq638IG5lZg_FFqZ4CJ8Q_dP7zWn_9Dxh_i68Zvhobv3lXHY2nagk/s1600/Track+2+%2528+twitter%2529.png" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="187" data-original-width="360" height="166" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj52vn_ikZdB5YeOwI9bq-a3yBDpxbt4I6k2LKFW40eZKARKKfr5exhIzyBgC8WYT8yq5CSaOumYvrjwzjVEv2ZtgLq638IG5lZg_FFqZ4CJ8Q_dP7zWn_9Dxh_i68Zvhobv3lXHY2nagk/s320/Track+2+%2528+twitter%2529.png" width="320" /></a></div>
<div class="separator" style="clear: both;">
<br /></div>
<br />
Good Pharmacovigilance Practices (GVP) begins with the acquisition of complete information from spontaneous adverse event reports. GVP characterizes the adverse event details, baseline patient characteristics, medical aid details, identification of the events and clinical course of the event. The role of excellent Pharmacovigilance observe and Pharmacoepidemology in Risk Management is principally to increase the chance of useful effects of a drug in a very population than the chance of adverse effects and to keep up the nice reportage Practices by avoiding the most important issues in risk management. conjointly it's vital to consider Signal investigation by gathering the knowledge on new or unknown drug effects that's doubtless caused by a medication which finally ought to result in making certain safety. The pharmacovigilance and clinical trials services providing corporations ought to have the Pharmacovigilance certification.<br />
<br />
Share your research @ Global Pharmacovigilance 2018 Conference.<br />
https://globalpharmacovigilance.pharmaceuticalconferences.com/</div>
Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-4221054925840820447.post-31752039253716765442018-05-17T02:53:00.002-07:002018-05-17T03:50:56.548-07:00<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjsgUKTRAu96_6JhZCzxefmbgAKds83fAEZbAyePIhAFpvVfQNV6aySTvaX7mlomeSLQmMv685L3g9dobu5khg9RrfL8NHrgZvEnVS6vEbKvYHzQHNAjD4uOa1IWxVFcvYDn4a76ci5bb4/s1600/Screen-Shot-2017-05-26-at-11.47.52-AM.png" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="400" data-original-width="800" height="160" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjsgUKTRAu96_6JhZCzxefmbgAKds83fAEZbAyePIhAFpvVfQNV6aySTvaX7mlomeSLQmMv685L3g9dobu5khg9RrfL8NHrgZvEnVS6vEbKvYHzQHNAjD4uOa1IWxVFcvYDn4a76ci5bb4/s320/Screen-Shot-2017-05-26-at-11.47.52-AM.png" width="320" /></a></div>
<br /><br />The <a href="https://globalpharmacovigilance.pharmaceuticalconferences.com/call-for-abstracts.php">global pharmacovigilance</a> (PV) market size was estimated at USD 3.40 billion in 2016 and is anticipated to witness a CAGR of 13.1% over the forecast period. Increasing incidence of Adverse Drug Reactions (ADRs) is expected to accelerate the demand for pharmacovigilance services <br /><br />The main aim of <a href="https://globalpharmacovigilance.pharmaceuticalconferences.com/call-for-abstracts.php">pharmacovigilance</a> is to supply complete and clear info associated with drug safety and varied risks and advantages related to them. Pharmacovigilance will facilitate in providing info of unintended and severe <a href="https://globalpharmacovigilance.pharmaceuticalconferences.com/call-for-abstracts.php">adverse events</a> that couldn't be provided by clinical trials involving in-vivo technique. It enhances the impact of pharmacovigilance on patient welfare and public health and to grasp what's pharmacovigilance. This track offers a short discussion on Pharmacovigilance role in <a href="https://globalpharmacovigilance.pharmaceuticalconferences.com/call-for-abstracts.php">health care </a>system. Pharmacovigilance legislation offers associate degree outlook on the principles and laws to follow in Pharmacovigilance observe. The Role of <a href="https://globalpharmacovigilance.pharmaceuticalconferences.com/call-for-abstracts.php">pharmaceutical</a> company industries within the improvement of pharmacovigilance system is extremely crucial to take care of the protection knowledge, Detection and analysis of <a href="https://globalpharmacovigilance.pharmaceuticalconferences.com/call-for-abstracts.php">drug safety</a> signals through manual and medical devices reportage. Pharmacovigilance scope additionally deals as Ecopharmacovigilance (EPV), <a href="https://globalpharmacovigilance.pharmaceuticalconferences.com/call-for-abstracts.php">pharmacoenvironmentology</a> and pharmacovigilance in flavourer medicines. <br /><br />For more updates regarding the conference, mail us at globalpharmacovigilance123@gmail.com <br /><br />P.S: https://globalpharmacovigilanceconferences.blogspot.in/</div>
Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-4221054925840820447.post-37937631256875615052018-05-16T01:28:00.001-07:002018-05-16T01:48:49.504-07:00<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEivxRkJ0IEyBFHTielAOLSQQdC_tXmcnDUD9DSpqVsk_lCLXaIg260IMbT0TPQqrWtnjFxE5MyT-qOXzIj8u02zmtVtLb0ck7JYCgrPHFqcqEkSKW-d1050QEkebCvYzR9PXXVbsTREM14/s1600/Adobe+Spark+%25283%2529.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="400" data-original-width="700" height="182" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEivxRkJ0IEyBFHTielAOLSQQdC_tXmcnDUD9DSpqVsk_lCLXaIg260IMbT0TPQqrWtnjFxE5MyT-qOXzIj8u02zmtVtLb0ck7JYCgrPHFqcqEkSKW-d1050QEkebCvYzR9PXXVbsTREM14/s320/Adobe+Spark+%25283%2529.jpg" width="320" /></a></div>
<div style="background-color: white; box-sizing: border-box; color: #333333; font-family: "Roboto Slab", serif; font-size: 13px; margin-bottom: 10px;">
</div>
Global Pharmacovigilance 2018 is comprised of #keynote and #speakers sessions on latest cutting edge research designed to offer comprehensive global #discussions that address current #issues in Global #Pharmacovigilance 2018<br />
<br />
<div>
<a href="https://globalpharmacovigilance.pharmaceuticalconferences.com/abstract-submission.php">Submit your abstract</a> to any of the mentioned tracks<br />
<br />
Track 1: Pharmacovigilance Significance & Scope<br />
Track 2: Good Pharmacovigilance Practice<br />
Track 3: Adverse Drug Reaction<br />
Track 4: Drug Safety<br />
Track 5: Pharmacokinetics and Pharmacodynamics<br />
Track 6: Innovations in Pre-clinical Research<br />
Track 7: Clinical Research<br />
Track 8: Clinical Trials<br />
Track 9: Innovations in Clinical Trials<br />
Track 10: ClinicalTrials on Various #Disorders<br />
Track 11: Clinical Data Management and #Statistics<br />
Track 12: Clinical and Medical Case Reports<br />
Track 13: Pharmacovigilance and #Risk Management<br />
Track 14: RegulatoryAffairs<br />
Track 15: Challenges in Pharmacy Practice<br />
Track 16: Pharmaceutical Toxicology</div>
</div>
Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-4221054925840820447.post-56092951304085963942018-05-14T22:23:00.001-07:002018-05-16T01:47:14.468-07:00<div dir="ltr" style="text-align: left;" trbidi="on">
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhTjtuychGfX6xmQskf0Wh31SCILxTOG4ETFRukpaUdMm2eCqb45DK_Erk8yekIEJU5ORi1s-2m4to46d9flg3Ej7tDE0QDFkMlSEZw1uCpSzbtYHJfbF8M7eJ_s_2wEGNJV8Z40vNl9xQ/s1600/Bannerr.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="530" data-original-width="700" height="242" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhTjtuychGfX6xmQskf0Wh31SCILxTOG4ETFRukpaUdMm2eCqb45DK_Erk8yekIEJU5ORi1s-2m4to46d9flg3Ej7tDE0QDFkMlSEZw1uCpSzbtYHJfbF8M7eJ_s_2wEGNJV8Z40vNl9xQ/s320/Bannerr.jpg" width="320" /></a></div>
With the grand success of <a href="https://globalpharmacovigilance.pharmaceuticalconferences.com/">Pharmacovigilance</a> Series of Conferences in UK, USA in consecutive years over the last several years which met with great achievement in Business Conferencing. It’s glad to announce <a href="http://globalpharmacovigilance.pharmaceuticalconferences.com/">12th Global Pharmacovigilance & Drug Safety Summit</a> during July 16-17, 2018 Sydney, Australia with the theme “Comprehend Multiple Facets of Pharmacovigilance, Drug Safety and Clinical Trials”. This is a 2 day Mega Event offering <a href="http://globalpharmacovigilance.pharmaceuticalconferences.com/exhibition.php">Exhibition</a>, at venue to showcase the new and emerging technologies with Keynote presentation, <a href="http://globalpharmacovigilance.pharmaceuticalconferences.com/speaker-guidelines.php">Oral</a>, <a href="http://globalpharmacovigilance.pharmaceuticalconferences.com/young-researchers-forum.php">YRF</a> (Student Presentation), <a href="http://globalpharmacovigilance.pharmaceuticalconferences.com/poster-presentation.php">poster</a>, <a href="http://globalpharmacovigilance.pharmaceuticalconferences.com/eposter-presentation.php">e-poster</a> Presentations.<br /></div>
Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-4221054925840820447.post-40694919422556884322017-11-02T21:32:00.002-07:002017-11-30T20:14:57.869-08:00GLOBAL PHARMACOVIGILANCE 2018<div dir="ltr" style="text-align: left;" trbidi="on">
With the grand success of Pharmacovigilance Series of Conferences in UK, USA in consecutive years over the last several years which met with great achievement in Business Conferencing. It’s glad to announce<b> 12th Global Pharmacovigilance & Drug Safety Summit during July 16-17, 2018 Sydney, Australia with the theme “Comprehend Multiple Facets of Pharmacovigilance, Drug Safety and Clinical Trials”.</b> This is a 2 day Mega Event offering Exhibition, at venue to showcase the new and emerging technologies with Keynote presentation, Oral, YRF (Student Presentation), poster, e-poster Presentations.<br />
<br />
<h2 class="heading-highlights" style="background: rgb(56, 138, 187); border-radius: 4px 4px 0px 0px; box-shadow: rgba(0, 0, 0, 0.2) 1px 1px 1px; box-sizing: border-box; color: white; font-family: "Helvetica Neue", Helvetica, Arial, sans-serif; font-size: 22px; font-weight: 500; line-height: 1.1; margin: 0px; padding: 5px 45px; position: relative;">
Conference Highlights</h2>
<div>
<br /></div>
<div>
<div class="MsoNormal" style="line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in;">
</div>
<ul style="text-align: left;">
<li><a href="http://globalpharmacovigilance.pharmaceuticalconferences.com/events-list/pharmacovigilance-significance-scope" style="font-family: "Times New Roman", serif; font-size: 12pt;" title="Pharmacovigilance Significance & Scope"><span style="color: #b98642; text-decoration-line: none;">Pharmacovigilance Significance &
Scope</span></a></li>
<li><a href="http://globalpharmacovigilance.pharmaceuticalconferences.com/events-list/good-pharmacovigilance-practice" style="font-family: "Times New Roman", serif; font-size: 12pt;" title="Good Pharmacovigilance Practice"><span style="color: #b98642; text-decoration-line: none;">Good Pharmacovigilance Practice</span></a></li>
<li><a href="http://globalpharmacovigilance.pharmaceuticalconferences.com/events-list/adverse-drug-reaction" style="font-family: "Times New Roman", serif; font-size: 12pt;" title="Adverse Drug Reaction"><span style="color: #b98642; text-decoration-line: none;">Adverse Drug Reaction</span></a></li>
<li><a href="http://globalpharmacovigilance.pharmaceuticalconferences.com/events-list/drug-safety" style="font-family: "Times New Roman", serif; font-size: 12pt;" title="Drug Safety"><span style="color: #b98642; text-decoration-line: none;">Drug Safety</span></a></li>
<li><a href="http://globalpharmacovigilance.pharmaceuticalconferences.com/events-list/pharmacokinetics-and-pharmacodynamics" style="font-family: "Times New Roman", serif; font-size: 12pt;" title="Pharmacokinetics and Pharmacodynamics"><span style="color: #b98642; text-decoration-line: none;">Pharmacokinetics and Pharmacodynamics</span></a></li>
<li><a href="http://globalpharmacovigilance.pharmaceuticalconferences.com/events-list/innovations-in-pre-clinical-research" style="font-family: "Times New Roman", serif; font-size: 12pt;" title="Innovations in Pre-clinical Research"><span style="color: #b98642; text-decoration-line: none;">Innovations in Pre-clinical Research</span></a></li>
<li><a href="http://globalpharmacovigilance.pharmaceuticalconferences.com/events-list/clinical-research" style="font-family: "Times New Roman", serif; font-size: 12pt;" title="Clinical Research "><span style="color: #b98642; text-decoration-line: none;">Clinical Research</span></a></li>
<li><a href="http://globalpharmacovigilance.pharmaceuticalconferences.com/events-list/clinical-trials" style="font-family: "Times New Roman", serif; font-size: 12pt;" title="Clinical Trials"><span style="color: #b98642; text-decoration-line: none;">Clinical Trials</span></a></li>
<li><a href="http://globalpharmacovigilance.pharmaceuticalconferences.com/events-list/innovations-in-clinical-trials" style="font-family: "Times New Roman", serif; font-size: 12pt;" title="Innovations in Clinical Trials"><span style="color: #b98642; text-decoration-line: none;">Innovations in Clinical Trials</span></a></li>
<li><a href="http://globalpharmacovigilance.pharmaceuticalconferences.com/events-list/clinical-trails-on-various-disorders" style="font-family: "Times New Roman", serif; font-size: 12pt;" title="Clinical Trails on Various Disorders"><span style="color: #b98642; text-decoration-line: none;">Clinical Trails on Various Disorders</span></a></li>
<li><a href="http://globalpharmacovigilance.pharmaceuticalconferences.com/events-list/clinical-data-management-and-statistics" style="font-family: "Times New Roman", serif; font-size: 12pt;" title="Clinical Data Management and Statistics"><span style="color: #b98642; text-decoration-line: none;">Clinical Data Management and
Statistics</span></a></li>
<li><a href="http://globalpharmacovigilance.pharmaceuticalconferences.com/events-list/clinical-and-medical-case-reports" style="font-family: "Times New Roman", serif; font-size: 12pt;" title="Clinical and Medical Case Reports"><span style="color: #b98642; text-decoration-line: none;">Clinical and Medical Case Reports</span></a></li>
<li><a href="http://globalpharmacovigilance.pharmaceuticalconferences.com/events-list/pharmacovigilance-and-risk-management" style="font-family: "Times New Roman", serif; font-size: 12pt;" title="Pharmacovigilance and Risk Management"><span style="color: #b98642; text-decoration-line: none;">Pharmacovigilance and Risk Management</span></a></li>
<li><a href="http://globalpharmacovigilance.pharmaceuticalconferences.com/events-list/regulatory-affairs" style="font-family: "Times New Roman", serif; font-size: 12pt;" title="Regulatory Affairs"><span style="color: #b98642; text-decoration-line: none;">Regulatory Affairs</span></a></li>
<li><a href="http://globalpharmacovigilance.pharmaceuticalconferences.com/events-list/challenges-in-pharmacy-practice" style="font-family: "Times New Roman", serif; font-size: 12pt;" title="Challenges in Pharmacy Practice"><span style="color: #b98642; text-decoration-line: none;">Challenges in Pharmacy Practice</span></a></li>
<li><span style="color: #b98642; font-family: "times new roman" , serif; font-size: 12pt;"><a href="http://globalpharmacovigilance.pharmaceuticalconferences.com/events-list/pharmaceutical-toxicology" style="font-family: "Times New Roman", serif; font-size: 12pt;" title="Pharmaceutical Toxicology">Pharmaceutical Toxicology</a></span></li>
</ul>
<br />
<div style="background-color: white; color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px;">
<h2 class="heading-highlights" style="background: rgb(56, 138, 187); border-radius: 4px 4px 0px 0px; box-shadow: rgba(0, 0, 0, 0.2) 1px 1px 1px; box-sizing: border-box; color: white; font-family: "Helvetica Neue", Helvetica, Arial, sans-serif; font-size: 22px; font-weight: 500; line-height: 1.1; margin: 0px; padding: 5px 45px; position: relative;">
Special Issues</h2>
<div>
<br /></div>
</div>
<div>
<div style="background-color: white;">
<ul style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px; line-height: 1.4; margin: 0.5em 0px; padding: 0px 2.5em; text-align: justify;">
<li style="margin: 0px 0px 0.25em; padding: 0px;"><span style="text-align: left;"> All accepted abstracts will be published in respective Supporting International Journals.</span></li>
<li style="margin: 0px 0px 0.25em; padding: 0px;"><span style="text-align: left;"> Abstracts will be provided with Digital Object Identifier by Cross Ref.</span></li>
</ul>
<br style="font-size: 13.2px; text-align: justify;" />
<div style="text-align: left;">
<div style="text-align: left;">
<b style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px; text-align: justify;">See more at: </b><span style="color: #0000ee; font-family: arial, tahoma, helvetica, freesans, sans-serif;"><span style="font-size: 13.2px;"><b><u><a href="https://globalpharmacovigilance.pharmaceuticalconferences.com/">https://globalpharmacovigilance.pharmaceuticalconferences.com/</a></u></b></span></span></div>
</div>
</div>
</div>
<div class="MsoNormal">
<o:p></o:p></div>
</div>
</div>
Pharmaceutica Conferencehttp://www.blogger.com/profile/00120422206847995770noreply@blogger.com9